iNtRON Biotechnology, Inc. - Current Ratio

The Current Ratio as of August 2026 (TTM) for iNtRON Biotechnology, Inc. (048530.KQ) is 9.56

According to iNtRON Biotechnology, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 9.56. This represents a change of -6.26% compared to the average of 10.20 of the last 4 quarters.

iNtRON Biotechnology, Inc. (048530.KQ) Historical Current Ratio (quarterly & annually)

How has 048530.KQ Current Ratio performed in the past?

The mean historical Current Ratio of iNtRON Biotechnology, Inc. over the last ten years is 16.65. The current 9.56 Current Ratio has changed 5.64% with respect to the historical average. Over the past ten years (40 quarters), 048530.KQ's Current Ratio was at its highest in in the December 2023 quarter at 77.59. The Current Ratio was at its lowest in in the September 2016 quarter at 0.

iNtRON Biotechnology, Inc. (048530.KQ) Current Ratio by Quarter and Year

Discovering the peaks and valleys of iNtRON Biotechnology, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

iNtRON Biotechnology, Inc. (048530.KQ) Average Current Ratio

How has 048530.KQ Current Ratio performed in the past?

The current Current Ratio of iNtRON Biotechnology, Inc. (048530.KQ) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

iNtRON Biotechnology, Inc. (048530.KQ) Current Ratio vs. Peers

How is 048530.KQ’s Current Ratio compared to its peers?

iNtRON Biotechnology, Inc.’s Current Ratio is greater than Oncocross Co., Ltd. (3.75), greater than CG Invites Co., Ltd. (0.34), greater than Sugentech Inc. (9.11), greater than Ildong Holdings Co., Ltd. (0.81), greater than Encell Co. Ltd. (9.07), greater than Aprogen Biologics Inc. (0.57), greater than Cellid, Co., Ltd. (0.57), greater than CKD Bio Corp. (1.06), greater than Hyundai Pharmaceutical Co., Ltd. (1.69), less than ORIENT BIO Inc. (14.09),

Build a custom stock screener for iNtRON Biotechnology, Inc. (048530.KQ) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like iNtRON Biotechnology, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

iNtRON Biotechnology, Inc. (048530.KQ) and other stocks custom spreadsheet templates

The easiest way to analyze a company like iNtRON Biotechnology, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.